Regular Ol’ Intensity

My personal viewpoint is that the anticipated probability of this man with a p16+ tumor of intermediate bulk being alive at 5 years is ∼70% if treated with standard fractionation and ∼85% if treated with concurrent platinum and radiation. I think that the risk of the toxicities of 2 to 3 cycles of cisplatin is worth this perceived benefit. 1 Simon A.B. Mell L.K. To intensify or not to intensify? Consideration of competing risks in the management...